Journal article
Personalized medicine and stroke prevention: Where are we?
J Kim, AG Thrift, MR Nelson, CF Bladin, DA Cadilhac
Vascular Health and Risk Management | Published : 2015
DOI: 10.2147/VHRM.S77571
Abstract
There are many recommended pharmacological and non-pharmacological therapies for the prevention of stroke, and an ongoing challenge is to improve their uptake. Personalized medicine is seen as a possible solution to this challenge. Although the use of genetic information to guide health care could be considered as the apex of personalized medicine, genetics is not yet routinely used to guide prevention of stroke. Currently personalized aspects of prevention of stroke include tailoring interventions based on global risk, the utilization of individualized management plans within a model of organized care, and patient education. In this review we discuss the progress made in these aspects of pr..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The STAND FIRM trial was funded by the NHMRC (586605). Thanks to Sue Mosley and Mary Staios who undertook the education visits for the STAND FIRM trial.